Related Experiment Video
Updated: Dec 24, 2025

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer
Moonsun Jung1,2, Jixuan Gao1, Leanna Cheung1
1Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW Australia, Kensington, New South Wales, Australia.
Abstract:
Epithelial ovarian cancer (EOC) is a complex disease comprising discrete histological and molecular subtypes, for which survival rates remain unacceptably low. Tailored approaches for this deadly heterogeneous disease are urgently needed. Efflux pumps belonging to the ATP-binding cassette (ABC) family of transporters are known for roles in both drug resistance and cancer biology and are also highly targetable. Here we have investigated the association of ABCC4/MRP4 expression to clinical outcome and its biological function in endometrioid and serous tumors, common histological subtypes of EOC. We found high expression of ABCC4/MRP4, previously shown to be directly regulated by c-Myc/N-Myc, was associated with poor prognosis in endometrioid EOC (P = .001) as well as in a subset of serous EOC with a "high-MYCN" profile (C5/proliferative; P = .019). Transient siRNA-mediated suppression of MRP4 in EOC cells led to reduced growth, migration and invasion, with the effects being most pronounced in endometrioid and C5-like serous cells compared to non-C5 serous EOC cells. Sustained knockdown of MRP4 also sensitized endometrioid cells to MRP4 substrate drugs. Furthermore, suppression of MRP4 decreased the growth of patient-derived EOC cells in vivo. Together, our findings provide the first evidence that MRP4 plays an important role in the biology of Myc-associated ovarian tumors and highlight this transporter as a potential therapeutic target for EOC.
Insights
High expression of ATP-binding cassette subfamily C member 4 (ABCC4/MRP4) correlates with poor outcomes in ovarian cancer subtypes. Suppressing MRP4 reduced tumor growth and invasion, identifying it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Epithelial ovarian cancer (EOC) is a heterogeneous disease with poor survival rates.
- ATP-binding cassette (ABC) transporters, like ABCC4/MRP4, are implicated in drug resistance and cancer progression.
- Targeting specific molecular pathways is crucial for developing effective EOC treatments.
Purpose of the Study:
- To investigate the association of ABCC4/MRP4 expression with clinical outcomes in EOC subtypes.
- To elucidate the biological function of ABCC4/MRP4 in endometrioid and serous EOC.
- To evaluate ABCC4/MRP4 as a potential therapeutic target in EOC.
Main Methods:
- Analysis of ABCC4/MRP4 expression in relation to patient prognosis.
- siRNA-mediated suppression of MRP4 in EOC cell lines.
- Assessment of cell growth, migration, and invasion following MRP4 knockdown.
- Evaluation of drug sensitivity in MRP4-suppressed cells.
- In vivo studies using patient-derived EOC cells.
Main Results:
- High ABCC4/MRP4 expression is linked to poor prognosis in endometrioid EOC and a subset of serous EOC (high-MYCN profile).
- MRP4 suppression reduced EOC cell growth, migration, and invasion, particularly in endometrioid and C5-like serous subtypes.
- Knockdown of MRP4 increased sensitivity to MRP4 substrate drugs in endometrioid EOC cells.
- In vivo, MRP4 suppression inhibited the growth of patient-derived EOC xenografts.
Conclusions:
- ABCC4/MRP4 plays a significant role in the biology of Myc-associated ovarian tumors.
- MRP4 is a potential therapeutic target for specific subtypes of epithelial ovarian cancer.
- Targeting MRP4 may offer a novel strategy to improve treatment outcomes for EOC patients.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...